About Cerium Pharmaceuticals
Cerium Pharmaceuticals is a Healthcare company based in Gaithersburg (United States) founded in 2012 by Nancy Klett and Gregg Lapointe. Drugs for orphan diseases are developed and commercialised by Cerium. It operates on a HealthTech model. Cerium Pharmaceuticals has raised $12.67 million across 5 funding rounds. Its chief executive, as recorded, is Gregg Lapointe. Cerium Pharmaceuticals offers products and services including Corticotropin (ACTH) Porcine (Synthetic). Its focus areas include Biotechnology and Rare Disease Treatments. Its legal entity is Cerium Pharmaceuticals, Inc. Its competitors include AllStripes, Zenas BioPharma and CTI Clinical Trial; 2 of its 3 listed competitors have raised funding.
Company details
Cerium Pharmaceuticals is engaged in developing therapies for patients with rare kidney diseases. The company is primarily focused on creating the first approved drug for Primary Membranous Nephropathy (PMN), a rare condition affecting approximately 75,000 patients in the US. Solutions are being advanced through clinical trials, including a Phase 3 trial for an investigational drug product. The sector of operation includes biotechnology with an emphasis on rare and orphan diseases.
- Headquarters Gaithersburg, United States
- Founders Nancy Klett, Gregg Lapointe
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website ceriumpharma.com
- Social LinkedIn
- Legal Name Cerium Pharmaceuticals, Inc.
- Total Equity Funding$12.67M (USD)
in 5 rounds
- Latest Funding Round$750K (USD), Series A
May 2026
Products & Services of Cerium Pharmaceuticals
Cerium Pharmaceuticals offers a comprehensive portfolio of products and services, including Corticotropin (ACTH) Porcine (Synthetic).
Investigational drug developed for treating rare kidney disease.
Funding Insights of Cerium Pharmaceuticals
Cerium Pharmaceuticals has successfully raised a total of $12.67M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $750 thousand completed in May 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $12.67M
- Total Rounds 5
- Last Round Series A — $750,000
- First Round $2.27M
(Jun 2016)
All 5 funding rounds of Cerium Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2026 | $750,000 | Series A | – | – | – |
| May 2026 | $750,000 | Series A | – | – | – |
| Jul 2021 | $8.9M | Series A | – | – | – |
| May 2021 | $1.91M | Debt – Conventional | – | – | – |
| Jun 2016 | $2.27M | Seed | – | – | – |
People of Cerium Pharmaceuticals
7 people are tracked at Cerium Pharmaceuticals (5 in leadership, 2 in board & advisors).
| Name | Role | Group |
|---|---|---|
Nancy Klett | Co-Founder | Leadership |
Gregg Lapointe | Co-Founder & CEO | Leadership |
Şemsi Burak Derkunt | Chief Scientific Officer | Leadership |
Robert J. Rubin | Chief Medical Officer | Leadership |
Brian Schreiber | MD – Chief Medical Officer (2015 To 2021) | Leadership |
James Gale | Board Member | Board & advisors |
Thomas A. Depasquale | Chairperson | Board & advisors |
Complete people profiles for Cerium Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cerium Pharmaceuticals
3 dated milestones of Cerium Pharmaceuticals across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Cerium Pharmaceuticals is founded.
- Funding First funding round of $2.3M.
- Funding Latest funding round, Series A, of $750K.
Competitors of Cerium Pharmaceuticals
Cerium Pharmaceuticals has 3 listed competitors in our database, 2 of them funded. They include AllStripes, Zenas BioPharma and CTI Clinical Trial.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| allstripes.com | 2017 | San Francisco, United States | $67M | Provider of information to patients and communities with the medical data for rare diseases | ||
| zenasbio.com | 2020 | Fort Myers, United States | $318.15M | Clinical development services for autoimmune and rare diseases are provided. | ||
| ctifacts.com | 1999 | Cincinnati, United States | Provides clinical trials, consulting, and regulatory services in healthcare sectors. |
Detailed competitors of Cerium Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cerium Pharmaceuticals
The website of Cerium Pharmaceuticals (ceriumpharma.com) receives about 1.6K visits a month.
- Monthly visits1.6K
▲ 106.8% vs previous month
Websites whose visitors overlap most with Cerium Pharmaceuticals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| taslyus.com | 100% | View details | |||
| vicihealthsciences.com | 100% | 7.9K | #2,765,324 | View details | |
| exegipharma.com | 98% | 2.1K | #7,496,544 | View details | |
apacpharma.com | apacpharma.com | 86% | – |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Cerium Pharmaceuticals (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cerium Pharmaceuticals
Cerium Pharmaceuticals was founded in 2012 and raised its 1st funding round 4 years after it was founded.
Cerium Pharmaceuticals is headquartered in Gaithersburg, United States. It is registered at Gaithersburg, Maryland, United States.
Gregg Lapointe is the CEO of Cerium Pharmaceuticals, as recorded in our data. They have also founded this company.
Cerium Pharmaceuticals is a funded company, having raised a total of $12.67M across 5 funding rounds to date. The company's 1st funding round was a Seed of $2.27M, raised on Jun 2016.
Cerium Pharmaceuticals is engaged in developing therapies for patients with rare kidney diseases. The company is primarily focused on creating the first approved drug for Primary Membranous Nephropathy (PMN), a rare condition affecting approximately 75,000 patients in the US. Solutions are being advanced through clinical trials, including a Phase 3 trial for an investigational drug product. The sector of operation includes biotechnology with an emphasis on rare and orphan diseases.
Cerium Pharmaceuticals's top competitors include Zenas BioPharma, AllStripes and CTI Clinical Trial.
Cerium Pharmaceuticals offers Corticotropin (ACTH) Porcine (Synthetic).
Cerium Pharmaceuticals operates through Cerium Pharmaceuticals, Inc..